TY - JOUR AB - Gliomas are highly malignant tumors with a rapid progression and poor prognosis. The present study investigated the cellular effects of CLN5‑knockdown in the glioblastoma (GBM) U251 and U87MG cell lines. The Cell Counting Kit‑8 and colony formation assays indicated that CLN5‑knockdown inhibited the proliferation of GBM cells. Additionally, the results of the Transwell and scratch assays revealed that CLN5‑knockdown significantly inhibited migration and invasion, and the flow cytometry analysis confirmed that apoptosis was promoted. Knockdown of CLN5 downregulated the expression levels of MMP‑2, Bcl‑2, cyclin D1, CDK4 and CDK6, and upregulated the expression levels of Bax and activated caspase‑9. Additionally, it blocked GBM cells in the G1‑phase and induced early apoptosis. Knockdown of CLN5 inhibited the activation of the Akt and mTOR signaling pathways in GBM by decreasing the levels of phosphorylated (p)‑Akt and p‑mTOR. The present data suggested that downregulation of CLN5 may be a potential treatment option for GBM. Knockdown of CLN5 inhibited the development of GBM via the inhibition of the Akt and mTOR signaling pathways. AD - Department of Neurology, Shandong University of Qilu Hospital, Jinan, Shandong 250012, P.R. China Department of Critical Medicine, The Third People's Hospital of Heze, Heze, Shandong 274000, P.R. China Department of Geriatrics, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250011, P.R. China AU - Xing,Jiexia AU - Li,Ying AU - Zhao,Huilan DA - 2021/05/01 DO - 10.3892/ol.2021.12648 IS - 5 JO - Oncol Lett KW - CLN5 glioblastoma U251 U87MG Akt/mTOR pathway apoptosis PY - 2021 SN - 1792-1074 1792-1082 SP - 387 ST - Knockdown of CLN5 inhibits the tumorigenic properties of glioblastoma cells via the Akt/mTOR signaling pathway T2 - Oncology Letters TI - Knockdown of CLN5 inhibits the tumorigenic properties of glioblastoma cells via the Akt/mTOR signaling pathway UR - https://doi.org/10.3892/ol.2021.12648 VL - 21 ER -